Hsbc Holdings »

Denali Therapeutics shares owned by Hsbc Holdings

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Hsbc Holdings from 13F filings

Historical chart of Hsbc Holdings investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Hsbc Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Hsbc Holdings

Quarter filed Position value Share count Share price at filing
2023-12-31 $363k 17k 21.46
2023-09-30 $360k 17k 20.63
2023-03-31 $310k 14k 22.90
2022-12-31 $260k 9.3k 27.81
2022-09-30 $239k 7.7k 31.14